A qualitative study on experiences of HIV vaccine trial participants in a phase I/II double-blinded, randomized placebo-controlled clinical trial in Tanzania: Lessons for COVID-19 vaccine testing
Erica S. Sanga
Erica S. Sanga
1NIMR-Mwanza Medical Research Centre, Mwanza, Tanzania. 2NIMR-Mbeya Medical Research Centre (MMRC), Mbeya, Tanzania. 3The School of Public Health, University of Western Cape, South Africa.
The School of Public Health, University of Western Cape, South Africa., 5Foundation for Professional Development, Health Systems Strengthening Division, Pretoria, South Africa. 6The University of the Witwatersrand, School of Public Health, Johannesburg, South Africa.